China Jo-Jo Drugstores, Inc. (CJJD) Stock Analysis

China Jo-Jo Drugstores, Inc. (CJJD) Healthcare & Pipeline Overview

China Jo-Jo Drugstores, Inc. retails and distributes pharmaceutical and healthcare products in China, operating through retail drugstores, online platforms, wholesale, and herb farming. With a focus on traditional Chinese medicine (TCM) and Western medicine, the company operates retail pharmacies and online stores, facing competition in China's evolving healthcare market.

What Is the Investment Thesis for CJJD?

China Jo-Jo Drugstores, Inc. presents a unique investment proposition within the Chinese healthcare market, characterized by its integrated approach to retail pharmacy, online sales, wholesale distribution, and herb farming. With a market capitalization of $0.01 billion and a P/E ratio of 0.00, the company's valuation metrics suggest potential undervaluation relative to its earnings. The company's profit margin of 8.5% and gross margin of 3.2% indicate areas for improvement in operational efficiency and cost management. Key growth catalysts include expanding its online pharmacy presence to capitalize on the growing e-commerce trend in China, and leveraging its TCM herb farming operations to meet increasing demand for traditional medicine. However, investors may want to evaluate the potential risks associated with operating in a highly regulated market, including evolving healthcare policies and pricing pressures. The company's beta of -0.15 suggests a low correlation with the broader market, potentially offering downside protection during market downturns.

Based on FMP financials and quantitative analysis

CJJD Key Highlights

Market capitalization of $0.01 billion, indicating a small-cap company with potential for growth.

• P/E ratio of 0.00, suggesting the company may be undervalued compared to its earnings.
• Profit margin of 8.5%, reflecting the company's profitability in the pharmaceutical retail sector.
• Gross margin of 3.2%, indicating the percentage of total sales revenue that the company retains after incurring the direct costs associated with producing the goods and services it sells.
• Operated 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, as well as 4 drugstores as of March 31, 2021, demonstrating a significant retail presence.

Who Are CJJD's Competitors?

CJJD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are CJJD's Key Strengths?

Established retail pharmacy network in China.

• Integration of traditional Chinese medicine (TCM) with Western medicine.
• Online pharmacy platform providing convenient access to healthcare products.
• Herb farming operations ensuring a stable supply of TCM ingredients.

What Are CJJD's Weaknesses?

Relatively small market capitalization compared to larger competitors.

• Gross margin of 3.2% indicates potential inefficiencies.
• Limited geographic diversification outside of China.
• Dependence on regulatory approvals for pharmaceutical products.

What Could Drive CJJD Stock Higher?

Expansion of online pharmacy platform to increase market reach and sales.

• Leveraging TCM expertise to develop new products and services for domestic and international markets.
• Strategic partnerships with other healthcare providers or technology companies to enhance capabilities.
• Efforts to improve operational efficiency and increase profit margins.

What Are the Key Risks for CJJD?

Financial-distress signal — its Altman Z-Score of 1.39 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Intense competition from other pharmaceutical retailers and online pharmacies.
• Evolving healthcare regulations and pricing pressures in China.
• Product recalls or safety concerns related to pharmaceutical products.
• Fluctuations in the cost of raw materials for TCM herbs.
• Dependence on regulatory approvals for pharmaceutical products.

What Are the Growth Opportunities for CJJD?

• Expansion of Online Pharmacy Platform: China Jo-Jo Drugstores can capitalize on the increasing e-commerce penetration in China by expanding its online pharmacy platform. The Chinese online pharmacy market is projected to reach $49.7 billion in 2026, presenting a significant growth opportunity. By enhancing its online platform with a wider range of products, improved user experience, and strategic partnerships with e-commerce giants, the company can attract a larger customer base and drive online sales growth. Timeline: Ongoing.
• Leveraging Traditional Chinese Medicine (TCM): With the growing popularity of TCM in China and globally, China Jo-Jo Drugstores can leverage its herb farming operations to meet the increasing demand for TCM products. By expanding its herb cultivation and processing capabilities, the company can ensure a stable supply of high-quality TCM ingredients and develop new TCM-based products for both domestic and international markets. Timeline: Ongoing.
• Strategic Partnerships and Acquisitions: China Jo-Jo Drugstores can pursue strategic partnerships and acquisitions to expand its market reach and product offerings. Collaborating with other healthcare providers, pharmaceutical manufacturers, or technology companies can create synergies and enhance the company's competitive position. Acquiring smaller pharmacy chains or healthcare-related businesses can accelerate its expansion into new geographic areas or product categories. Timeline: Upcoming.
• Enhancing Retail Pharmacy Network: While already having a retail presence, China Jo-Jo Drugstores can optimize its existing network of retail pharmacies by improving store layouts, product assortment, and customer service. Implementing data analytics to understand customer preferences and optimize inventory management can enhance sales and profitability. Expanding the range of healthcare services offered at its pharmacies, such as health screenings and consultations, can also attract more customers. Timeline: Ongoing.
• Expanding Drug Wholesale Business: China Jo-Jo Drugstores can increase its revenue by expanding its drug wholesale business. By establishing partnerships with more pharmaceutical manufacturers and distributors, the company can increase the volume of products it distributes. Focusing on niche or specialized pharmaceutical products can also provide a competitive advantage. Timeline: Ongoing.

What Are CJJD's Competitive Advantages?

• Established retail pharmacy network in China.
• Integration of traditional Chinese medicine (TCM) with Western medicine.
• Online pharmacy platform providing convenient access to healthcare products.
• Herb farming operations ensuring a stable supply of TCM ingredients.

What Does CJJD Do?

Founded in 2003 and headquartered in Hangzhou, China, China Jo-Jo Drugstores, Inc. has evolved into a multifaceted healthcare company operating across various segments of the pharmaceutical industry. The company's primary business involves retailing and distributing pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices. These products are offered through its network of retail drugstores, operating under the Jiuzhou Grand Pharmacy name, and its online pharmacy platforms. The company also provides convenience products, such as consumable, seasonal, and promotional items. China Jo-Jo Drugstores distinguishes itself by integrating traditional and Western medical practices, offering on-site consultations with licensed doctors of Western medicine and TCM. This approach caters to a broad customer base seeking both conventional and alternative healthcare solutions. In addition to its retail operations, the company engages in drug wholesale, distributing third-party pharmaceutical products to trading companies. It also cultivates and wholesales herbs used for TCM, further diversifying its revenue streams. As of March 31, 2021, China Jo-Jo Drugstores operated 109 retail pharmacies under the Jiuzhou Grand Pharmacy name, along with 4 additional drugstores, demonstrating its established presence in the Chinese pharmaceutical retail market.

What Products and Services Does CJJD Offer?

• Operates retail drugstores under the Jiuzhou Grand Pharmacy name.
• Sells prescription and over-the-counter drugs.
• Offers nutritional supplements and traditional Chinese medicines (TCM).
• Provides personal and family care products and medical devices.
• Operates an online drugstore retailing OTC drugs and nutritional supplements.
• Sells products through third-party online platforms.
• Distributes third-party pharmaceutical products to trading companies.
• Cultivates and wholesales herbs used for TCM.

How Does CJJD Make Money?

• Retail sales of pharmaceutical products through physical stores.
• Online sales of pharmaceutical products through its online pharmacy.
• Wholesale distribution of pharmaceutical products to other companies.
• Cultivation and sale of herbs used in traditional Chinese medicine.

What Industry Does CJJD Operate In?

China Jo-Jo Drugstores operates within the rapidly evolving Chinese healthcare market, which is characterized by increasing demand for pharmaceutical products and healthcare services. The market is driven by factors such as an aging population, rising disposable incomes, and growing awareness of health and wellness. The competitive landscape includes both domestic and international players, ranging from large pharmaceutical manufacturers to retail pharmacy chains. China Jo-Jo Drugstores differentiates itself through its integrated business model, combining retail pharmacy, online sales, wholesale distribution, and herb farming. The company's focus on traditional Chinese medicine (TCM) also provides a unique selling proposition in a market where TCM remains highly valued.

Who Are CJJD's Key Customers?

• Individual consumers seeking prescription and over-the-counter medications.
• Customers interested in nutritional supplements and personal care products.
• Patients seeking traditional Chinese medicine (TCM) remedies.
• Trading companies purchasing pharmaceutical products for distribution.

China Jo-Jo Drugstores, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.39 places it in the distress zone, a signal of elevated financial risk.

Return on equity for China Jo-Jo Drugstores, Inc. stands at 41.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 20.2%, showing how much profit it generates from its asset base. CJJD trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~21.50x. A current ratio of 1.82 indicates the company holds enough short-term assets to cover its near-term obligations.

Company Profile

China Jo-Jo Drugstores, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Hangzhou, CN. The company is led by CEO Lei Liu. CJJD has traded publicly since 2009.

The most recent 11 insider filings for China Jo-Jo Drugstores, Inc. break down as 1 sales and 10 purchases. On net that is roughly 2.4M shares acquired (about $2.1M) — insiders putting money in tends to read as conviction.

CJJD Financials

CJJD Latest News

What Investors Ask About China Jo-Jo Drugstores, Inc. (CJJD) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources